Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized ...

On a per-share basis, the Boston-based company said it had profit of 37 cents. Earnings, adjusted for investment costs, were ...

Bain Capital Specialty Finance, Inc. (BCSF) Q2 2025 Management View CEO Michael Alexander Ewald highlighted "Q2 net investment income per share was $0.47, representing an annualized yield on book ...

Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized initial public offering in the United States, indicating robust investor ...

Bain Capital Specialty Finance Inc (NYSE:BCSF) is set to release its Q2 2025 earnings on Aug 5, 2025. The consensus estimate ...

Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial ...

Bain Capital and 11North Partners paid $395 million for a portfolio of 10 shopping centers in Florida and South Carolina, ...

Bristol Myers partners with Bain Capital to launch a new autoimmune-focused biotech, out-licensing five key immunology assets ...

Bristol Myers Squibb (BMS) and Bain Capital have created an independent biopharmaceutical company to develop immunology ...

A newly-acquired Bain Capital company in Japan that makes airplane seats, toilets and galleys is betting its US-based ...

A joint venture between Bain Capital and 11North Partners has purchased a portfolio of 10 open-air retail centers in Florida ...

The new company will work on five experimental drugs licensed from Bristol Myers, including a late-stage lupus treatment and ...